Combination intraperitoneal chemotherapy is superior to mitomycin C or oxaliplatin for colorectal carcinomatosis in vivo
Mark S. Cohen, Mazin F. Al-Kasspooles, Stephen K. Williamson, David Henry, Melinda Broward, Katherine F. Roby
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Combination intraperitoneal chemotherapy is superior to mitomycin C or oxaliplatin for colorectal carcinomatosis in vivo'. Together they form a unique fingerprint.